Premier Alternatives

Tasso

Diagnostic Equipment · Seattle, WA · Founded 2012 · Privately Held (backing)

Manufacturer of blood collection devices intended to facilitate self-collection of blood samples. Tasso is based in Seattle, WA and was founded in 2012. It was valued at $229 million at its later-stage round in Nov 2021, the last priced event on record. It has raised $123 million across 1 recorded round; the latest was a $99.5 million Series B in Nov 2021.

PMV mark · valuation
$229.5M
Oct 2026
Priced at
its later-stage round
Nov 2021
Total raised
$122.7M
Last round
Later Stage VC (Series B)
Nov 2021

Tasso key facts

as of Oct 2026
  • Manufacturer of blood collection devices intended to facilitate self-collection of blood samples.
  • Tasso is valued at approximately $229.5M as of Oct 2026, set at its later-stage round, Nov 2021; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $122.7M across 1 recorded rounds; the latest was Later Stage VC (Series B) ($99.5M) in Nov 2021.
  • Notable investors include Techstars, MedTech Innovator, RA Capital Management, United States Department of War, SVB Financial Group (Dallas) — 24 tracked in total.
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$229.5M

Valued at $229.5M at its later-stage round, Nov 2021. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Tasso with a free account
  • ·The complete investor list: 24 names
  • ·Watch Tasso: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Tasso funding rounds

1 rounds
Nov 2021Later Stage VC (Series B)$99.5M▮
Full funding history →

Tasso valuation

Tasso was valued at $229 million at its later-stage round in Nov 2021. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Tasso raised?

Tasso has raised $123 million across 1 recorded round since 2021. The largest was a $99.5 million Series B in Nov 2021.

Tasso investors

24 investors are on record for Tasso, including Techstars, MedTech Innovator, RA Capital Management and United States Department of War. By type, the record holds 5 venture capital firms and 1 hedge fund. The Series B in Nov 2021 drew 11 investors.

Comparable companies

Comparable diagnostic equipment names by valuation on PrivateMarketView: SiPhox Health ($185 million), NanoMosaic ($85 million) and AOA (Diagnostic Equipment) ($65 million).

About Tasso

Manufacturer of blood collection devices intended to facilitate self-collection of blood samples. The company's devices are disposable, small in size, and have an interchangeable cartridge to ensure that the right blood preparation starts as soon as the sample is taken, enabling patients to painlessly administer their blood samples and mail them back to the lab for analysis in a hassle-free manner.

Industry
Diagnostic Equipment
Sector
Healthcare
HQ
Seattle, WA, United States
Founded
2012
Employees
100
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.